APLT Applied Therapeutics, Inc.

Nasdaq www.appliedtherapeutics.com


$ 0.33 $ 0.00 (0 %)    

Friday, 14-Nov-2025 04:06:22 EST
QQQ $ 606.61 $ 0.00 (0 %)
DIA $ 474.75 $ 0.00 (0 %)
SPY $ 671.40 $ 0.00 (0 %)
TLT $ 89.22 $ 0.00 (0 %)
GLD $ 383.81 $ 0.00 (0 %)
$ 0.27
$ 0.56
$ 0.33 x 200
$ 0.35 x 353
-- - --
$ 0.27 - $ 10.48
42,855,422
na
38.96M
$ 1.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 04-14-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-10-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-18-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-11-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-13-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-12-2019 06-30-2019 10-Q
27 06-21-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 applied-therapeutics-tanks-as-fda-path-for-lead-rare-disease-drug-turns-uncertain

Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD...

 applied-therapeutics-q3-eps-013-beats-014-estimate-sales-1000m

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of ...

 4-biotech-stocks-seeing-explosive-momentum-gains

The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

 applied-therapeutics-meets-with-fda-on-potential-drug-filing-for-rare-nerve-disease-cmt-sord

Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating trans...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 applied-therapeutics-q2-eps-015-beats-016-estimate

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of ...

 reported-sunday-applied-therapeutics-reports-24-month-data-from-inspire-trial-showing-govorestat-slows-disease-progression-in-cmt-sord-reinforces-plans-for-2025-nda

 Slowing of progression of disease observed via MRI at 24 monthsImprovements in outcomes and reduction in sorbitol maintained t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION